Markers for Identifying and Targeting Glioblastoma Cells during Surgery

被引:13
|
作者
Schipmann, Stephanie [1 ]
Schwake, Michael [1 ]
Molina, Eric Suero [1 ]
Stummer, Walter [2 ]
机构
[1] Univ Hosp Munster, Dept Neurosurg, Albert Schweitzer Campus 1,Bldg A1, D-48149 Munster, Germany
[2] UK Munster, NCH, Munster, Germany
关键词
glioma; interoperative MRI; 5-ALA; fluorescein; indocyanine green; HIGH-GRADE GLIOMAS; FLUORESCENCE-GUIDED RESECTION; GROSS TOTAL RESECTION; INDOCYANINE GREEN VIDEOANGIOGRAPHY; SURGICAL MICROSCOPE FILTER; PROSPECTIVE PHASE-II; BRAIN-TUMOR SURGERY; 5-AMINOLEVULINIC ACID; VOLUMETRIC-ANALYSIS; MALIGNANT GLIOMAS;
D O I
10.1055/s-0039-1692976
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma is a highly malignant tumor with a poor prognosis. A factor influencing survival that can be affected by the surgeon is the extent of resection (EOR). Due to the infiltrative nature of the tumor, delineation of tumor from normal brain parenchyma is often challenging. To improve EOR and facilitate tumor visualization, several techniques have been developed over the last few years. This literature review presents an overview of current intraoperative strategies for identifying and targeting glioma cells and discusses the benefits and limitations of each technique. Along with conventional techniques such as neuronavigation and ultrasound, fluorescence-guided surgery with different fluorescent agents such as 5-aminolevulinc acid and fluorescein have been widely used. Recently, newer techniques have emerged and are being translated into the operating room, promising delineation of glioblastoma tissue using targeted approaches or identification on a microscopic level, for instance using Raman spectroscopy or confocal microscopy.
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [21] Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
    Chernov, Alexandr N.
    Kim, Alexandr V.
    Skliar, Sofia S.
    Fedorov, Evgeniy V.
    Tsapieva, Anna N.
    Filatenkova, Tatiana A.
    Chutko, Aleksei L.
    Matsko, Marina V.
    Galimova, Elvira. S.
    Shamova, Olga V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (05) : 455 - 469
  • [22] Overcoming challenges in glioblastoma treatment: targeting infiltrating cancer cells and harnessing the tumor microenvironment
    Chiariello, Mario
    Inzalaco, Giovanni
    Barone, Virginia
    Gherardini, Lisa
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [23] Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
    Yudintceva, Natalia
    Lomert, Ekaterina
    Mikhailova, Natalia
    Tolkunova, Elena
    Agadzhanian, Nikol
    Samochernych, Konstantin
    Multhoff, Gabriele
    Timin, Grigoriy
    Ryzhov, Vyacheslav
    Deriglazov, Vladimir
    Mazur, Anton
    Shevtsov, Maxim
    BIOMEDICINES, 2021, 9 (11)
  • [24] Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA
    Prabhu, Antony
    Sarcar, Bhaswati
    Kahali, Soumen
    Shan, Yuan
    Chinnaiyan, Prakash
    PLOS ONE, 2012, 7 (12):
  • [25] MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT
    Zhen, Limin
    Li, Jian
    Zhang, Mingran
    Yang, Kun
    JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI, 2016, 23 : 1 - 10
  • [26] Glioblastoma: pathology, molecular mechanisms and markers
    Aldape, Kenneth
    Zadeh, Gelareh
    Mansouri, Sheila
    Reifenberger, Guido
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2015, 129 (06) : 829 - 848
  • [27] Safe surgery for glioblastoma: Recent advances and modern challenges
    Gerritsen, Jasper Kees Wim
    Broekman, Marike Lianne Daphne
    De Vleeschouwer, Steven
    Schucht, Philippe
    Nahed, Brian Vala
    Berger, Mitchel Stuart
    Vincent, Arnaud Jean Pierre Edouard
    NEURO-ONCOLOGY PRACTICE, 2022, 9 (05) : 364 - 379
  • [28] Predictors of survival in elderly patients undergoing surgery for glioblastoma
    Voisin, Mathew R.
    Sasikumar, Sanskriti
    Zadeh, Gelareh
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [29] CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
    Han, Jianfeng
    Chu, Jianhong
    Chan, Wing Keung
    Zhang, Jianying
    Wang, Youwei
    Cohen, Justus B.
    Victor, Aaron
    Meisen, Walter H.
    Kim, Sung-hak
    Grandi, Paola
    Wang, Qi-En
    He, Xiaoming
    Nakano, Ichiro
    Chiocca, E. Antonio
    Glorioso, Joseph C., III
    Kaur, Balveen
    Caligiuri, Michael A.
    Yu, Jianhua
    SCIENTIFIC REPORTS, 2015, 5
  • [30] Systems Medicine for Precise Targeting of Glioblastoma Systems Medicine Against Glioblastoma
    Zeng, Jie
    Zeng, Xiao Xue
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (10) : 1565 - 1584